Dechra Pharmaceuticals (LSE:DPH) Effective Interest Rate on Debt % : 11.15% (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Dechra Pharmaceuticals's annualized positive value of Interest Expense for the quarter that ended in Jun. 2023 was £56.6 Mil. Dechra Pharmaceuticals's average total debt for the quarter that ended in Jun. 2023 was £507.9 Mil. Therefore, Dechra Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 was 11.15%.

Dechra Pharmaceuticals Effective Interest Rate on Debt % Historical Data

The historical data trend for Dechra Pharmaceuticals's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dechra Pharmaceuticals Effective Interest Rate on Debt % Chart

Dechra Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

3.50

3.47

2.91

3.77

10.53

Dechra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															3.08	3.02	4.58	7.43	11.15

Competitive Comparison of Dechra Pharmaceuticals's Effective Interest Rate on Debt %

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Effective Interest Rate on Debt % falls into.

Dechra Pharmaceuticals Effective Interest Rate on Debt % Calculation

Dechra Pharmaceuticals's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Jun. 2022 )	+	Total Debt (A: Jun. 2023 ))	/ count )
=	-1 * -43.9	/	( (329.1	+	504.5)	/ 2 )
=	-1 * -43.9	/	416.8
=	10.53 %

where

	Total Debt (A: Jun. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	325.8	+	3.3
=	329.1

	Total Debt (A: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	500.6	+	3.9
=	504.5

Dechra Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2022 )	+	Total Debt (Q: Jun. 2023 ))	/ count )
=	-1 * -56.6	/	( (511.2	+	504.5)	/ 2 )
=	-1 * -56.6	/	507.85
=	11.15 %

where

	Total Debt (Q: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	508	+	3.2
=	511.2

	Total Debt (Q: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	500.6	+	3.9
=	504.5

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Dechra Pharmaceuticals (LSE:DPH) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Dechra Pharmaceuticals Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

DPHAY:USA DPHl:UK 1PK:Germany

Address

24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA

Website

https://www.dechra.com

Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines